Nilutamide[ (Nilandron) ] Drug Information

Contains Nilutamide drug information and provides Nilutamide drug indication, contraindication, special concerns, side effects, overdose management and dosage
Search Drugs by Generic or Trade Name:
Browse Drugs by Generic Name:
[ A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z ]

List of Contents:
  • Indications
  • Contraindications
  • Special Concerns
  • Side Effects
  • Overdose Management
  • Dosage

  • Indications:
    In combination with surgical castration for the treatment of metastatic prostate cancer (stage D2).
    Back to Top
    Severe hepatic impairment, severe respiratory insufficiency, hypersensitivity to nilutamide.
    Back to Top
    Special Concerns:
    Many clients experience a delay in adaptation to the dark ranging from seconds to a few minutes. Safety and efficacy have not been determined in children.
    Back to Top
    Side Effects:
    GI: Nausea, constipation, dry mouth, diarrhea, hepatitis, GI disorder, GI hemorrhage melena. CNS: Dizziness, paresthesia, nervousness. CV: Hypertension, heart failure angina, syncope. Respiratory: Interstitial pneumonitis, dyspnea, lung disorder, increased cough, rhinitis. Metabolic/nutritional: Edema, weight loss, intolerance to alcohol. Ophthalmic: Cataract, photophobia, impaired adaptation to dark, abnormal vision. Miscellaneous: Leukopenia, hot flushes, UTI, malaise, pruritus, arthritis, aplastic anemia (rare).
    Back to Top
    Overdose Management:
    No Available information
    Back to Top
    Drug Interactions:
    Phenytoin / Phenytoin metabolism delayed elimination and risk of toxicity Theophylline / Theophylline metabolism delayed elimination and risk of toxicity Vitamin K antagonists / Metabolism of vitamin K antagonists delayed elimination and risk of toxicity
    Back to Top
    •Tablets Metastatic prostate cancer.

    300 mg (six 50-mg tablets) once daily for 30 days followed by 150 mg (three 50-mg tablets) once daily.
    Back to Top